Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Climent

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Medicina Clinica|October 19, 1991
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups]R Blanco Guerrero, J R Germà Lluch, M A Climent Durán, et al.
European Urology|January 1, 1992
Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testisJ R Germá Lluch, M A Seguí Palmer, M A Climent Durán, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
Long term prognosis of juvenile absence epilepsyM Aiguabella Macau, M Falip Centellas, M Veciana de Las Heras, et al.
In Vivo (Athens, Greece)|November 1, 1993
Oncogenic proteins and prognostic correlations in breast cancerR Molina, X Filelia, M A Segui, et al.
Medicina Clinica|November 2, 1991
[Lymphomas originating in the otorhinolaryngeal region: 10 years' experience]M A Climent, C Pallarés Curto, R Blanco Guerrero, et al.
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Acta Otorrinolaringologica Espanola|March 29, 2001
[Experience in the treatment of 98 carcinomas of the nasopharynx. Long-term follow-up and analysis of prognostic factors]C Gaspar, E Zapater, M Chust, et al.
Journal of Geriatric Oncology|August 20, 2025
Pilot phase 2 study of the efficacy, safety, and tolerability of first-line cabozantinib for older fragile patients with metastatic renal cell carcinoma: The SOGUG-CABOMAYOR studyMiguel A Climent, Ricardo Sanchez-Escribano, Lucía Heras, et al.
British Journal of Cancer|March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancerX Garcia del Muro, E Marcuello, J Gumá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Medicina Clinica|October 19, 1991
[The modification of the toxicity produced by chemotherapy in testicular cancer by adapting its intensity to prognostic groups]R Blanco Guerrero, J R Germà Lluch, M A Climent Durán, et al.
European Urology|January 1, 1992
Intensive chemotherapy in poor-prognosis nonseminomatous germ cell tumors of the testisJ R Germá Lluch, M A Seguí Palmer, M A Climent Durán, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
Long term prognosis of juvenile absence epilepsyM Aiguabella Macau, M Falip Centellas, M Veciana de Las Heras, et al.
In Vivo (Athens, Greece)|November 1, 1993
Oncogenic proteins and prognostic correlations in breast cancerR Molina, X Filelia, M A Segui, et al.
Medicina Clinica|November 2, 1991
[Lymphomas originating in the otorhinolaryngeal region: 10 years' experience]M A Climent, C Pallarés Curto, R Blanco Guerrero, et al.
Actas Urologicas Espanolas|September 25, 2012
[Recomendations on the management of controversies in advanced castrate-resistant prostate cancer]J M Cózar, E Solsona, J Morote, et al.
Acta Otorrinolaringologica Espanola|March 29, 2001
[Experience in the treatment of 98 carcinomas of the nasopharynx. Long-term follow-up and analysis of prognostic factors]C Gaspar, E Zapater, M Chust, et al.
Journal of Geriatric Oncology|August 20, 2025
Pilot phase 2 study of the efficacy, safety, and tolerability of first-line cabozantinib for older fragile patients with metastatic renal cell carcinoma: The SOGUG-CABOMAYOR studyMiguel A Climent, Ricardo Sanchez-Escribano, Lucía Heras, et al.
British Journal of Cancer|March 5, 2002
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancerX Garcia del Muro, E Marcuello, J Gumá, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 24, 2021
SEOM clinical guidelines for the treatment of advanced prostate cancer (2020)A González Del Alba, M J Méndez-Vidal, S Vazquez, et al.
Pageof 10